We are live on ! Find out more
EXAS icon

Exact Sciences

Delisted

EXAS was delisted on the 20th of March, 2026.

573 hedge funds and large institutions have $9.7B invested in Exact Sciences in 2025 Q3 according to their latest regulatory filings, with 79 funds opening new positions, 201 increasing their positions, 180 reducing their positions, and 60 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more first-time investments, than exits

New positions opened: 79 | Existing positions closed: 60

29% more call options, than puts

Call options by funds: $133M | Put options by funds: $103M

12% more repeat investments, than reductions

Existing positions increased: 201 | Existing positions reduced: 180

2% more funds holding

Funds holding: 561 → 573 (+12)

0.78% less ownership

Funds ownership: 94.65% → 93.87% (-0.78%)

1% less capital inflows, than outflows

Capital inflows: $1.45B | Capital outflows: $1.47B

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
573
Holders Change
+12
Holders Change %
+2.14%
% of All Funds
7.48%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.05%
New
79
Increased
201
Reduced
180
Closed
60
Calls
$133​M
Puts
$103​M
Net Calls
+$29.9​M
Net Calls Change
+$75.3​M

EXAS Hedge Fund Activity: Q3 2025 in Review

573 of the 7,660 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q3 2025, worth a combined $9.7B — up 2.4% from $9.49B a quarter earlier.

Buyers outnumbered sellers: 79 funds opened new EXAS positions and 60 closed out — a net gain of 19 holders — while 201 added to existing stakes and 180 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $175M. The largest seller was Fidelity Investments, cutting an estimated $412M.

  • 573 institutional investors held Exact Sciences (EXAS) as of Q3 2025, up from 561 in Q2 2025.
  • Funds reported $9.7B of Exact Sciences stock for Q3 2025, up 2.4% quarter-over-quarter.
  • 79 funds opened new Exact Sciences positions in Q3 2025 and 60 closed out, a net change of +19 holders.
  • The largest Exact Sciences buyer in Q3 2025 was Citadel Advisors, an estimated $175M added.
  • The largest Exact Sciences seller in Q3 2025 was Fidelity Investments, an estimated $412M sold.

Based on aggregated 13F filings for Q3 2025.